A Multi-site, Individually Randomized, Controlled Translation Trial of Integrated and Comprehensive Care Strategies to Reduce Cardiovascular Disease (CVD) Risk Among 1,120 Type 2 Diabetes Mellitus(T2DM) Patients in South Asia (CARRS)
Developing and Testing Integrated, Multi-factorial Cardiovascular Disease Risk Reduction Strategies in South Asia (CARRS Translation Trial)
Sponsor: Aga Khan University
A NA clinical study on Dyslipidaemia and Hypertension, this trial is ongoing. The trial is conducted by Aga Khan University and has accumulated 6 data snapshots since 2010. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
6 versions recorded-
Jul 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Jul 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status NA
First recorded
Oct 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aga Khan University
- All India Institute of Medical Sciences
- Madras Diabetes Research Foundation, Chennai
- National Heart, Lung, and Blood Institute (NHLBI)
- Public Health Foundation of India
- United Health Group, USA
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • #35, 5th Cross,Malleswaram Circle,, India
- • 2nd Floor, Golden Jubilee Block, Afzalgunj,, India
- • Bambolim, India
- • Dr. A. L. Nair Road, Mumbai Central,, India
- • Kochi, India
- • New Delhi, India
- • No 4 West Madha Church Street, Royapuram, India
- • P.O. BOx. 3500 Stadium, Road,, Pakistan
- • Road No 1, Banjara Hills,, India
- • Sarjapur Road, Koramangala,, India